{"pmid":32419720,"pmcid":"PMC7224643","title":"Understanding COVID-19: Digit ratio (2D:4D) and sex differences in national case fatality rates.","text":["Understanding COVID-19: Digit ratio (2D:4D) and sex differences in national case fatality rates.","Background: The reported national case fatality rates (CFRs) for coronavirus disease 2019 (COVID-19) shows a sex bias with males > females. The relative lengths of the index (2D) and ring (4D) fingers (digit ratio; 2D:4D) is a sexually dimorphic (males < females) proxy of fetal sex steroids (low 2D:4D indicates high prenatal testosterone/low prenatal estrogen). Aim: To examine sex-specific relationships of 2D:4D per nation with national values of COVID-19 CFRs. Study design: COVID-19 CFRs and the percent of male deaths were related to mean national (self-reported) 2D:4D by sex and hand from a large online survey (the BBC Internet Study). Subjects: 103,482 men and 83,366 women. Outcome measures: Relationships of mean national 2D:4D with CFRs from 41 countries and with national male death rates from 16 countries. Results: Male right and left hand 2D:4D showed positive relationships with CFR. These relationships remained significant after removing the influence of female 2D:4D. A positive association of male right and left 2D:4D was detected with the percentage of male deaths. Conclusions: At the national level, high mean 2D:4D (indicating low prenatal testosterone/high prenatal estrogen) is associated with high CFRs and percent male mortality. At the individual level, high 2D:4D may be a risk factor for severity of COVID-19 in males. We speculate that male 2D:4D is a negative correlate for expression of the SARS-CoV2 receptor (ACE2).","Early Hum Dev","Manning, John T","Fink, Bernhard","32419720"],"abstract":["Background: The reported national case fatality rates (CFRs) for coronavirus disease 2019 (COVID-19) shows a sex bias with males > females. The relative lengths of the index (2D) and ring (4D) fingers (digit ratio; 2D:4D) is a sexually dimorphic (males < females) proxy of fetal sex steroids (low 2D:4D indicates high prenatal testosterone/low prenatal estrogen). Aim: To examine sex-specific relationships of 2D:4D per nation with national values of COVID-19 CFRs. Study design: COVID-19 CFRs and the percent of male deaths were related to mean national (self-reported) 2D:4D by sex and hand from a large online survey (the BBC Internet Study). Subjects: 103,482 men and 83,366 women. Outcome measures: Relationships of mean national 2D:4D with CFRs from 41 countries and with national male death rates from 16 countries. Results: Male right and left hand 2D:4D showed positive relationships with CFR. These relationships remained significant after removing the influence of female 2D:4D. A positive association of male right and left 2D:4D was detected with the percentage of male deaths. Conclusions: At the national level, high mean 2D:4D (indicating low prenatal testosterone/high prenatal estrogen) is associated with high CFRs and percent male mortality. At the individual level, high 2D:4D may be a risk factor for severity of COVID-19 in males. We speculate that male 2D:4D is a negative correlate for expression of the SARS-CoV2 receptor (ACE2)."],"journal":"Early Hum Dev","authors":["Manning, John T","Fink, Bernhard"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32419720","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.earlhumdev.2020.105074","keywords":["ace2","covid-19","case fatality rate","coronavirus","digit ratio","testosterone"],"e_drugs":["Testosterone","Steroids"],"weight":0,"_version_":1667159284579827713,"score":9.490897,"similar":[{"pmid":32470767,"title":"Understanding COVID-19: Digit ratio (2D:4D) and sex differences in national case fatality rates.","text":["Understanding COVID-19: Digit ratio (2D:4D) and sex differences in national case fatality rates.","BACKGROUND: The reported national case fatality rates (CFRs) for coronavirus disease 2019 (COVID-19) shows a sex bias with males > females. The relative lengths of the index (2D) and ring (4D) fingers (digit ratio; 2D:4D) is a sexually dimorphic (males < females) proxy of fetal sex steroids (low 2D:4D indicates high prenatal testosterone/low prenatal estrogen). AIM: To examine sex-specific relationships of 2D:4D per nation with national values of COVID-19 CFRs. STUDY DESIGN: COVID-19 CFRs and the percent of male deaths were related to mean national (self-reported) 2D:4D by sex and hand from a large online survey (the BBC Internet Study). SUBJECTS: 103,482 men and 83,366 women. OUTCOME MEASURES: Relationships of mean national 2D:4D with CFRs from 41 countries and with national male death rates from 16 countries. RESULTS: Male right and left hand 2D:4D showed positive relationships with CFR. These relationships remained significant after removing the influence of female 2D:4D. A positive association of male right and left 2D:4D was detected with the percentage of male deaths. CONCLUSIONS: At the national level, high mean 2D:4D (indicating low prenatal testosterone/high prenatal estrogen) is associated with high CFRs and percent male mortality. At the individual level, high 2D:4D may be a risk factor for severity of COVID-19 in males. We speculate that male 2D:4D is a negative correlate for expression of the SARS-CoV2 receptor (ACE2).","Early Hum Dev","Manning, John T","Fink, Bernhard","32470767"],"abstract":["BACKGROUND: The reported national case fatality rates (CFRs) for coronavirus disease 2019 (COVID-19) shows a sex bias with males > females. The relative lengths of the index (2D) and ring (4D) fingers (digit ratio; 2D:4D) is a sexually dimorphic (males < females) proxy of fetal sex steroids (low 2D:4D indicates high prenatal testosterone/low prenatal estrogen). AIM: To examine sex-specific relationships of 2D:4D per nation with national values of COVID-19 CFRs. STUDY DESIGN: COVID-19 CFRs and the percent of male deaths were related to mean national (self-reported) 2D:4D by sex and hand from a large online survey (the BBC Internet Study). SUBJECTS: 103,482 men and 83,366 women. OUTCOME MEASURES: Relationships of mean national 2D:4D with CFRs from 41 countries and with national male death rates from 16 countries. RESULTS: Male right and left hand 2D:4D showed positive relationships with CFR. These relationships remained significant after removing the influence of female 2D:4D. A positive association of male right and left 2D:4D was detected with the percentage of male deaths. CONCLUSIONS: At the national level, high mean 2D:4D (indicating low prenatal testosterone/high prenatal estrogen) is associated with high CFRs and percent male mortality. At the individual level, high 2D:4D may be a risk factor for severity of COVID-19 in males. We speculate that male 2D:4D is a negative correlate for expression of the SARS-CoV2 receptor (ACE2)."],"journal":"Early Hum Dev","authors":["Manning, John T","Fink, Bernhard"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470767","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.earlhumdev.2020.105074","keywords":["ace2","covid-19","case fatality rate","coronavirus","digit ratio","testosterone"],"weight":0,"_version_":1668167110060146688,"score":2064.1436},{"pmid":32473009,"title":"Age-dependent gender differences of COVID-19 in mainland China: comparative study.","text":["Age-dependent gender differences of COVID-19 in mainland China: comparative study.","BACKGROUND: The ongoing pandemic of novel coronavirus disease 2019 (COVID-19) is challenging global public health system. Sex-differences in infectious diseases are a common but neglected problem. METHODS: We used the national surveillance database of COVID-19 in mainland China to compared gender differences in attack rate (AR), proportion of severe and critical cases (PSCC) and case fatality rate (CFR) in relation to age, affected province, and onset-to-diagnosis interval. RESULTS: The overall AR was significantly higher in female population than in males (63.9 versus 60.5 per million persons; P < .001). By contrast, PSCC and CFR were significantly lower among female patients (16.9% and 4.0%) than among males (19.5% and 7.2%), with ORs of 0.87 and 0.57, respectively (both P < .001). The female-to-male differences were age-dependent, which were significant among people aged 50-69 years for AR, and in the patients of 30-years or older for both PSCC and CFR (all P </= .001). The AR, PSCC and CFR varied greatly from province to province. However, female-to-male differences in AR, PSCC and CFR were significant in the epicenter, Hubei province, where 82.2% confirmed cases and 97.4% deaths occurred. After adjusting for age, affected province and onset-to-diagnosis interval, the female-to-male difference in AR, PSCC and CFR remained significant in multivariate logistic regression analyses. CONCLUSIONS: We elucidate an age-dependent gender dimorphism for COVID-19, in which the females have higher susceptibility but lower severity and fatality. Further epidemiological and biological investigations are required to better understand the sex-specific differences for effective interventions.","Clin Infect Dis","Qian, Jie","Zhao, Lin","Ye, Run-Ze","Li, Xiu-Jun","Liu, Yuan-Li","32473009"],"abstract":["BACKGROUND: The ongoing pandemic of novel coronavirus disease 2019 (COVID-19) is challenging global public health system. Sex-differences in infectious diseases are a common but neglected problem. METHODS: We used the national surveillance database of COVID-19 in mainland China to compared gender differences in attack rate (AR), proportion of severe and critical cases (PSCC) and case fatality rate (CFR) in relation to age, affected province, and onset-to-diagnosis interval. RESULTS: The overall AR was significantly higher in female population than in males (63.9 versus 60.5 per million persons; P < .001). By contrast, PSCC and CFR were significantly lower among female patients (16.9% and 4.0%) than among males (19.5% and 7.2%), with ORs of 0.87 and 0.57, respectively (both P < .001). The female-to-male differences were age-dependent, which were significant among people aged 50-69 years for AR, and in the patients of 30-years or older for both PSCC and CFR (all P </= .001). The AR, PSCC and CFR varied greatly from province to province. However, female-to-male differences in AR, PSCC and CFR were significant in the epicenter, Hubei province, where 82.2% confirmed cases and 97.4% deaths occurred. After adjusting for age, affected province and onset-to-diagnosis interval, the female-to-male difference in AR, PSCC and CFR remained significant in multivariate logistic regression analyses. CONCLUSIONS: We elucidate an age-dependent gender dimorphism for COVID-19, in which the females have higher susceptibility but lower severity and fatality. Further epidemiological and biological investigations are required to better understand the sex-specific differences for effective interventions."],"journal":"Clin Infect Dis","authors":["Qian, Jie","Zhao, Lin","Ye, Run-Ze","Li, Xiu-Jun","Liu, Yuan-Li"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32473009","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1093/cid/ciaa683","locations":["China","Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1668255193409519616,"score":364.7417},{"pmid":32448136,"title":"Application of CareDose 4D combined with Karl 3D technology in the low dose computed tomography for the follow-up of COVID-19.","text":["Application of CareDose 4D combined with Karl 3D technology in the low dose computed tomography for the follow-up of COVID-19.","BACKGROUND: Coronavirus disease 2019 (COVID-19) is a highly infectious disease caused by the new coronavirus. Previous studies have shown that the chest CT examination plays an important role in the diagnosis and monitoring of COVID-19. However, some patients with COVID-19 had low white blood cell counts and reduced lymphocyte ratios. Multiple CT examinations may cause radiation damages as well as increase the apoptosis of peripheral blood lymphocytes. A new low-dose CT method should be developed because the regular CT may aggravate the disease. METHOD: Sixty cases were randomly divided into the study group (n = 30) and control group (n = 30). The lung window was reconstructed by Karl 3D iterative technique in the study group. The image quality was subjectively evaluated by two senior chest group diagnostic physicians using a 5-point double-blind method. The value of CT measurement and its standard deviation (SD) was used as an objective evaluation criteria. The volume of CT dose index (CTDIvol), dose length product (DLP) and effective dose (ED) from the two groups were compared and analyzed statistically. RESULT: There was no significant difference in the occurrence rates of ground glass opacities, consolidation, crazy-paving pattern, fiber cable shadow and axial interstitial thickening between the study group and control group (p > 0.05). In addition, no significant difference was found for the subjective score of overall image quality and image noise level (SD) between the two groups (p > 0.05). However, significant differences was found in CTDIvol, DLP, and ED between the study group and the control group (p < 0.05). The effective dose of the study group was reduced by 76% compared to the control group. CONCLUSION: CareDose 4D low-dose scanning combined with Karl 3D iterative reconstruction technology can not only greatly reduce the radiation dose, but also provide images that meet the diagnostic criteria of COVID-19, which can be used as a routine method for the follow-up of COVID-19 patients.","BMC Med Imaging","Li, Jiawei","Wang, Xiao","Huang, Xiaolu","Chen, Fangxing","Zhang, Xuesong","Liu, Ying","Luo, Guangzuo","Xu, Xunhua","32448136"],"abstract":["BACKGROUND: Coronavirus disease 2019 (COVID-19) is a highly infectious disease caused by the new coronavirus. Previous studies have shown that the chest CT examination plays an important role in the diagnosis and monitoring of COVID-19. However, some patients with COVID-19 had low white blood cell counts and reduced lymphocyte ratios. Multiple CT examinations may cause radiation damages as well as increase the apoptosis of peripheral blood lymphocytes. A new low-dose CT method should be developed because the regular CT may aggravate the disease. METHOD: Sixty cases were randomly divided into the study group (n = 30) and control group (n = 30). The lung window was reconstructed by Karl 3D iterative technique in the study group. The image quality was subjectively evaluated by two senior chest group diagnostic physicians using a 5-point double-blind method. The value of CT measurement and its standard deviation (SD) was used as an objective evaluation criteria. The volume of CT dose index (CTDIvol), dose length product (DLP) and effective dose (ED) from the two groups were compared and analyzed statistically. RESULT: There was no significant difference in the occurrence rates of ground glass opacities, consolidation, crazy-paving pattern, fiber cable shadow and axial interstitial thickening between the study group and control group (p > 0.05). In addition, no significant difference was found for the subjective score of overall image quality and image noise level (SD) between the two groups (p > 0.05). However, significant differences was found in CTDIvol, DLP, and ED between the study group and the control group (p < 0.05). The effective dose of the study group was reduced by 76% compared to the control group. CONCLUSION: CareDose 4D low-dose scanning combined with Karl 3D iterative reconstruction technology can not only greatly reduce the radiation dose, but also provide images that meet the diagnostic criteria of COVID-19, which can be used as a routine method for the follow-up of COVID-19 patients."],"journal":"BMC Med Imaging","authors":["Li, Jiawei","Wang, Xiao","Huang, Xiaolu","Chen, Fangxing","Zhang, Xuesong","Liu, Ying","Luo, Guangzuo","Xu, Xunhua"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32448136","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1186/s12880-020-00456-5","keywords":["covid-19","caredose 4d","image quality","radiation dose"],"locations":["CTDIvol","Karl"],"topics":["Diagnosis"],"weight":1,"_version_":1667785214027366400,"score":268.0425},{"pmid":32353762,"pmcid":"PMC7172806","title":"Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study.","text":["Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study.","BACKGROUND: An outbreak of COVID-19 in Iran has spread throughout the country. Identifying the epidemiological characteristics of this disease will help to make appropriate decisions and thus control the epidemic. The aim of this study was characterization of the epidemiological features of COVID-19 in Iran. METHODS: In this retrospective study, data related to the epidemiological characteristics of COVID-19 patients admitted to Baqiyatallah Hospital in Tehran, Iran, from 19 February 2020 to 15 April 2020 have been analyzed and reported. Patient characteristics including age, gender and underlying diseases were investigated. Data were collected through patient records. Sex ratio, Case Fatality Rate (CFR) and daily trend of cases were also determined. A multiple logistic regression analysis was also performed to assess affecting factors on mortality. RESULTS: From February 19, 2020 to April 15, 2020, 12870 patients referred to the hospital emergency department, of which 2968 were hospitalized with COVID-19 diagnosis. The majority of cases were in the age group of 50 to 60 years of old. The male-to-female ratio was 1.93:1. A total of 239 deaths occurred among all cases for an overall CFR of 1.85% based on the total number of patients (both outpatient and inpatient) and 8.06% among hospitalized patients. Out of all patients 10.89% had comorbidity. Diabetes, chronic respiratory diseases, hypertension, cardiovascular diseases, chronic Kidney diseases and cancer were the most common comorbidities with 3.81, 2.02 , 1.99 , 1.25, 0.60 and 0.57 %, respectively. Male gender (OR=1.45, 95% CI: 1.08-1.96), older age (OR=1.05, 95% CI: 1.04-1.06) and having underlying diseases (OR=1.53, 95% CI: 1.04-2.24) were significantly associated with mortality. CONCLUSIONS: The results of this study showed that Male gender, older age and having comorbidities were significantly associated with the risk of death among COVID-19 patients. It is important to pay special attention to male elderly patients with underlying diseases.","J Clin Virol","Nikpouraghdam, Mohamad","Jalali Farahani, Alireza","Alishiri, GholamHossein","Heydari, Soleyman","Ebrahimnia, Mehdi","Samadinia, Hossein","Sepandi, Mojtaba","Jafari, Nematollah Jonaidi","Izadi, Morteza","Qazvini, Ali","Dorostkar, Ruhollah","Tat, Mahdi","Shahriary, Alireza","Farnoosh, Gholamreza","Hosseini Zijoud, Seyed Reza","Taghdir, Maryam","Alimohamadi, Yousef","Abbaszadeh, Sepideh","Gouvarchin Ghaleh, Hadi Esmaeili","Bagheri, Mahdi","32353762"],"abstract":["BACKGROUND: An outbreak of COVID-19 in Iran has spread throughout the country. Identifying the epidemiological characteristics of this disease will help to make appropriate decisions and thus control the epidemic. The aim of this study was characterization of the epidemiological features of COVID-19 in Iran. METHODS: In this retrospective study, data related to the epidemiological characteristics of COVID-19 patients admitted to Baqiyatallah Hospital in Tehran, Iran, from 19 February 2020 to 15 April 2020 have been analyzed and reported. Patient characteristics including age, gender and underlying diseases were investigated. Data were collected through patient records. Sex ratio, Case Fatality Rate (CFR) and daily trend of cases were also determined. A multiple logistic regression analysis was also performed to assess affecting factors on mortality. RESULTS: From February 19, 2020 to April 15, 2020, 12870 patients referred to the hospital emergency department, of which 2968 were hospitalized with COVID-19 diagnosis. The majority of cases were in the age group of 50 to 60 years of old. The male-to-female ratio was 1.93:1. A total of 239 deaths occurred among all cases for an overall CFR of 1.85% based on the total number of patients (both outpatient and inpatient) and 8.06% among hospitalized patients. Out of all patients 10.89% had comorbidity. Diabetes, chronic respiratory diseases, hypertension, cardiovascular diseases, chronic Kidney diseases and cancer were the most common comorbidities with 3.81, 2.02 , 1.99 , 1.25, 0.60 and 0.57 %, respectively. Male gender (OR=1.45, 95% CI: 1.08-1.96), older age (OR=1.05, 95% CI: 1.04-1.06) and having underlying diseases (OR=1.53, 95% CI: 1.04-2.24) were significantly associated with mortality. CONCLUSIONS: The results of this study showed that Male gender, older age and having comorbidities were significantly associated with the risk of death among COVID-19 patients. It is important to pay special attention to male elderly patients with underlying diseases."],"journal":"J Clin Virol","authors":["Nikpouraghdam, Mohamad","Jalali Farahani, Alireza","Alishiri, GholamHossein","Heydari, Soleyman","Ebrahimnia, Mehdi","Samadinia, Hossein","Sepandi, Mojtaba","Jafari, Nematollah Jonaidi","Izadi, Morteza","Qazvini, Ali","Dorostkar, Ruhollah","Tat, Mahdi","Shahriary, Alireza","Farnoosh, Gholamreza","Hosseini Zijoud, Seyed Reza","Taghdir, Maryam","Alimohamadi, Yousef","Abbaszadeh, Sepideh","Gouvarchin Ghaleh, Hadi Esmaeili","Bagheri, Mahdi"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32353762","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.jcv.2020.104378","keywords":["covid-19","case fatality rate","comorbidity","epidemiology","iran","sars-cov-2"],"locations":["Iran","Iran","Tehran","Iran"],"countries":["Iran, Islamic Republic of"],"countries_codes":["IRN|Iran, Islamic Republic of"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138495716950016,"score":262.29218},{"pmid":32407491,"title":"iBioProVis: Interactive Visualization and Analysis of Compound Bioactivity Space.","text":["iBioProVis: Interactive Visualization and Analysis of Compound Bioactivity Space.","SUMMARY: iBioProVis is an interactive tool for visual analysis of the compound bioactivity space in the context of target proteins, drugs, and drug candidate compounds. iBioProVis tool takes target protein identifiers and, optionally, compound SMILES as input, and uses the state-of-the-art non-linear dimensionality reduction method t-Distributed Stochastic Neighbor Embedding (t-SNE) to plot the distribution of compounds embedded in a 2-D map, based on the similarity of structural properties of compounds and in the context of compounds' cognate targets. Similar compounds, which are embedded to proximate points on the 2-D map, may bind the same or similar target proteins. Thus, iBioProVis can be used to easily observe the structural distribution of one or two target proteins' known ligands on the 2-D compound space, and to infer new binders to the same protein, or to infer new potential target(s) for a compound of interest, based on this distribution. Principal component analysis (PCA) projection of the input compounds is also provided, Hence the user can interactively observe the same compound or a group of selected compounds which is projected by both PCA and embedded by t-SNE. iBioProVis also provides detailed information about drugs and drug candidate compounds through cross-references to widely used and well-known databases, in the form of linked table views. Two use-case studies were demonstrated, one being on ACE2 protein which is SARS-CoV-2 Spike protein receptor. ACE2 binding compounds and 7 antiviral drugs were closely embedded in which two of them have been under clinical trial for COVID-19. AVAILABILITY AND IMPLEMENTATION: iBioProVis and its carefully filtered dataset are available at https://ibpv.kansil.org/ for public use. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.","Bioinformatics","Donmez, Ataberk","Rifaioglu, Ahmet Sureyya","Acar, Aybar","Dogana, Tunca","Cetin-Atalay, Rengul","Atalay, Volkan","32407491"],"abstract":["SUMMARY: iBioProVis is an interactive tool for visual analysis of the compound bioactivity space in the context of target proteins, drugs, and drug candidate compounds. iBioProVis tool takes target protein identifiers and, optionally, compound SMILES as input, and uses the state-of-the-art non-linear dimensionality reduction method t-Distributed Stochastic Neighbor Embedding (t-SNE) to plot the distribution of compounds embedded in a 2-D map, based on the similarity of structural properties of compounds and in the context of compounds' cognate targets. Similar compounds, which are embedded to proximate points on the 2-D map, may bind the same or similar target proteins. Thus, iBioProVis can be used to easily observe the structural distribution of one or two target proteins' known ligands on the 2-D compound space, and to infer new binders to the same protein, or to infer new potential target(s) for a compound of interest, based on this distribution. Principal component analysis (PCA) projection of the input compounds is also provided, Hence the user can interactively observe the same compound or a group of selected compounds which is projected by both PCA and embedded by t-SNE. iBioProVis also provides detailed information about drugs and drug candidate compounds through cross-references to widely used and well-known databases, in the form of linked table views. Two use-case studies were demonstrated, one being on ACE2 protein which is SARS-CoV-2 Spike protein receptor. ACE2 binding compounds and 7 antiviral drugs were closely embedded in which two of them have been under clinical trial for COVID-19. AVAILABILITY AND IMPLEMENTATION: iBioProVis and its carefully filtered dataset are available at https://ibpv.kansil.org/ for public use. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online."],"journal":"Bioinformatics","authors":["Donmez, Ataberk","Rifaioglu, Ahmet Sureyya","Acar, Aybar","Dogana, Tunca","Cetin-Atalay, Rengul","Atalay, Volkan"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32407491","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1093/bioinformatics/btaa496","locations":["Bioinformatics"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666802845640294401,"score":259.88443}]}